Rathbones Brothers »

Autolus Therapeutics Plc spon ads shares owned by Rathbones Brothers

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Rathbones Brothers from 13F filings

Historical chart of Rathbones Brothers investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Rathbones Brothers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Rathbones Brothers

Quarter filed Position value Share count Share price at filing
2024-06-30 $234k 67k 3.48
2024-03-31 $429k 67k 6.38
2023-09-30 $171k 73k 2.33

More positions owned by Rathbones Brothers

Microsoft Corporation (MSFT)
Amazon (AMZN)
Visa (V)
Alphabet Inc Class A cs (GOOGL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)
Thermo Fisher Scientific (TMO)
Alphabet Inc Class C cs (GOOG)
Berkshire Hathaway (BRK.B)
Coca-Cola Company (KO)
Accenture (ACN)
Adobe Systems Incorporated (ADBE)
Abbott Laboratories (ABT)
Costco Wholesale Corporation (COST)

View all positions for Rathbones Brothers

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Deep Track Capital
Polygon Management
Armistice Capital
Frazier Life Sciences Management
Affinity Asset Advisors
BlackRock
BlackRock
T. Rowe Price Associates
Deerfield Management Company
Laurion Capital Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Stempoint Capital

View all funds holding Autolus Therapeutics Plc spon ads